| Product NDC: | 0409-4092 |
| Proprietary Name: | COPPER |
| Non Proprietary Name: | CUPRIC CHLORIDE |
| Active Ingredient(s): | .4 mg/mL & nbsp; CUPRIC CHLORIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-4092 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018960 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100728 |
| Package NDC: | 0409-4092-01 |
| Package Description: | 25 VIAL, PLASTIC in 1 TRAY (0409-4092-01) > 10 mL in 1 VIAL, PLASTIC |
| NDC Code | 0409-4092-01 |
| Proprietary Name | COPPER |
| Package Description | 25 VIAL, PLASTIC in 1 TRAY (0409-4092-01) > 10 mL in 1 VIAL, PLASTIC |
| Product NDC | 0409-4092 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CUPRIC CHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100728 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | CUPRIC CHLORIDE |
| Strength Number | .4 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE] |